Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency's ...

"Not only is there no clinical trial showing an increase in breast cancer mortality, but there are also other tremendous long term health benefits," Makary added.

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...

The Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have ...

Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...

The FDA is reconsidering the black box warning on estrogen. Experts say it’s time for a change—find out what this means for ...

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

A decades-old label has scared women (and their doctors) away from safe and effective menopause treatment. That could finally change today.

US health authorities on Thursday began a reassessment of the risks surrounding Hormone Replacement Therapy (HRT), a ...

US health authorities are set Thursday to reassess Hormone Replacement Therapy (HRT), a treatment used by menopausal women ...